Bao Chai

Department Of Infectious Diseases And Shenzhen Key Lab Of Endogenous Infection
Shenzhen, 518055, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Correction to "Repurposing GSK2018682 Confers Dual Antibacterial and Antibiofilm Activity against Staphylococcus aureus".

Correction to "Repurposing GSK2018682 Confers Dual Antibacterial and Antibiofilm Activity against Staphylococcus aureus".

Journal: ACS infectious diseases
Published: March 31, 2026

Repurposing GSK2018682 Confers Dual Antibacterial and Antibiofilm Activity against Staphylococcus aureus.

Repurposing GSK2018682 Confers Dual Antibacterial and Antibiofilm Activity against Staphylococcus aureus.

Journal: ACS infectious diseases
Published: January 12, 2026

Antibacterial and anti-virulence activity of the repurposed agent SX-682 against Staphylococcus aureus.

Antibacterial and anti-virulence activity of the repurposed agent SX-682 against Staphylococcus aureus.

Journal: BMC microbiology
Published: January 06, 2026

Repurposing Azeliragon as a novel antibacterial agent against methicillin-resistant Staphylococcus aureus via combined membrane phospholipids and cell wall targeting.

Repurposing Azeliragon as a novel antibacterial agent against methicillin-resistant Staphylococcus aureus via combined membrane phospholipids and cell wall targeting.

Journal: Communications biology
Published: October 16, 2025

Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients.

Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients.

Journal: The Journal of dermatological treatment
Published: October 01, 2025

Evaluation of 3D biomimetic microcarriers for enhancing therapeutic efficacy of human umbilical cord mesenchymal stem cells in psoriasis treatment.

Evaluation of 3D biomimetic microcarriers for enhancing therapeutic efficacy of human umbilical cord mesenchymal stem cells in psoriasis treatment.

Journal: Frontiers in immunology
Published: August 17, 2025

From skin to spinal Cord: How IL-17a Drives psoriatic chronic itch.

From skin to spinal Cord: How IL-17a Drives psoriatic chronic itch.

Journal: Brain, behavior, and immunity
Published: August 11, 2025

FOXD3 promotes homologous recombination repair and genomic stability by facilitating MRE11-mediated DNA end resection.

FOXD3 promotes homologous recombination repair and genomic stability by facilitating MRE11-mediated DNA end resection.

Journal: Acta biochimica et biophysica Sinica
Published: June 14, 2025

IL-6-Mediated Neurogenic Inflammation Regulated by the Dorsal Root Ganglion Macrophages Exacerbates Imiquimod-Induced Psoriasis-Like Skin Lesions in Mice.

IL-6-Mediated Neurogenic Inflammation Regulated by the Dorsal Root Ganglion Macrophages Exacerbates Imiquimod-Induced Psoriasis-Like Skin Lesions in Mice.

Journal: The Journal of investigative dermatology
Published: March 25, 2025

Cr(VI)-Responsive Ink with Four-Dimensional Printing of an Ultracompact Hydrogel Optical Fiber Microsensor.

Cr(VI)-Responsive Ink with Four-Dimensional Printing of an Ultracompact Hydrogel Optical Fiber Microsensor.

Journal: ACS sensors
Published: February 07, 2025

A novel lncRNA YIL163C enhances genomic stability and antifungal resistance via the DNA damage response in Saccharomyces cerevisiae.

A novel lncRNA YIL163C enhances genomic stability and antifungal resistance via the DNA damage response in Saccharomyces cerevisiae.

Journal: Frontiers in microbiology
Published: February 06, 2025

ALKBH5 exacerbates psoriatic dermatitis in mice by promoting angiogenesis.

ALKBH5 exacerbates psoriatic dermatitis in mice by promoting angiogenesis.

Journal: Frontiers of medicine
Published: November 02, 2024
Showing 1-12 of 25

Last Updated: 09/26/2026